Literature DB >> 6128681

Typical and atypical neuroleptics are potent antagonists at alpha 1-adrenoceptors of the dorsal lateral geniculate nucleus. An electrophysiological study.

J Marwaha, G K Aghajanian.   

Abstract

The present electrophysiology studies examined the actions of neuroleptics at central alpha 1-adrenoceptors in the rat. In single-cell recording experiments, typical and atypical neuroleptics, when administered systemically or locally (iontophoresis and pressure ejection), were found to be potent antagonists of activating alpha 1-adrenoceptor responses in the dorsal lateral geniculate nucleus (dLGN). Doses of neuroleptics effective as antagonists at alpha 1-adrenoceptors had very weak effects at muscarinic receptors in the dLGN. Since doses of neuroleptics employed in the present study were within the clinical range, it appears likely that central alpha 1-adrenoceptors would be blocked during a neuroleptic therapy in humans.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6128681     DOI: 10.1007/bf00586345

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  32 in total

1.  The noradrenergic cyclic AMP generating system in the rat limbic forebrain and its stereospecificity for butaclamol.

Authors:  S E Robinson; F Sulser
Journal:  J Pharm Pharmacol       Date:  1976-08       Impact factor: 3.765

2.  Human prolactin responses to neuroleptic drugs correlate with antischizophrenic potency.

Authors:  G Langer; E J Sachar; P H Gruen; F S Halpern
Journal:  Nature       Date:  1977-04-14       Impact factor: 49.962

3.  Inhibiton of neurons in the amygdala by dorsal raphe stimulation: mediation through a direct serotonergic pathway.

Authors:  R Y Wang; G K Aghajanian
Journal:  Brain Res       Date:  1977-01-14       Impact factor: 3.252

4.  Is the low incidence of extrapyramidal side-effects of antipsychotics associated with antimuscarinic properties?

Authors:  P M Laduron; J E Leysen
Journal:  J Pharm Pharmacol       Date:  1978-02       Impact factor: 3.765

5.  Neuroleptic drug interactions with norepinephrine alpha receptor binding sites in rat brain.

Authors:  S J Peroutka; D C U'Prichard; D A Greenberg; S H Snyder
Journal:  Neuropharmacology       Date:  1977-09       Impact factor: 5.250

6.  Activation of lateral geniculate neurons by norepinephrine: mediation by an alpha-adrenergic receptor.

Authors:  M A Rogawski; G K Aghajanian
Journal:  Brain Res       Date:  1980-01-27       Impact factor: 3.252

7.  Effects of clozapine, thioridazine, perlapine and haloperidol on the metabolism of the biogenic amines in the brain of the rat.

Authors:  H R Bürki; W Ruch; H Asper
Journal:  Psychopharmacologia       Date:  1975

8.  Binding characteristics of 3H-prazosin to rat brain alpha-adrenergic receptors.

Authors:  P Greengrass; R Bremner
Journal:  Eur J Pharmacol       Date:  1979-05-01       Impact factor: 4.432

9.  Clozapine versus perphenazine: the value of the biochemical mode of action of neuroleptics in predicting their therapeutic activity.

Authors:  H M Van Praag; J Korf; L C Dols
Journal:  Br J Psychiatry       Date:  1976-12       Impact factor: 9.319

10.  6-(4-Methyl-1-piperazinyl)morphanthridine (Perlapine), a new tricyclic compound with sedative and sleep-promoting properties. A pharmacological study.

Authors:  G Stille; A Sayers; H Lauener; E Eichenberger
Journal:  Psychopharmacologia       Date:  1973-02-20
View more
  3 in total

1.  Noradrenergic modulation of midbrain dopamine cell firing elicited by stimulation of the locus coeruleus in the rat.

Authors:  J Grenhoff; M Nisell; S Ferré; G Aston-Jones; T H Svensson
Journal:  J Neural Transm Gen Sect       Date:  1993

2.  Peripheral and central adrenoceptor modulation of the behavioural effects of clozapine in the paw test.

Authors:  E P Prinssen; B A Ellenbroek; A R Cools
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

3.  Antagonism of the hypothermic effect of clozapine in mice by centrally-active alpha 2-adrenergic antagonists and alpha 1-adrenergic agonists.

Authors:  M K Menon; R L Lloyd; L J Fitten
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.